Novartis further invests in cell and gene therapy manufacture, after Kymriah approval
Novartis plans to step up its capabilities of manufacturing cell and gene therapies with a new facility to be built in Stein, Switzerland.
Archives for August 29, 2018
FDA approves treatment for rare type of lymphoma
US Food and Drug Administration (FDA) has approved Poteligeo, a treatment for two rare non-Hodgkin lymphomas.
Bluebird cell therapy research to be advanced in AI collaboration
Bluebird bio and Gritstone Oncology have collaborated to research, develop and commercialize cancer treatments using cell therapy with an AI platform.